미숙아의 조기 혈소판 감소증의 원인과 신생아기 임상적 결과
Causes and Neonatal Outcome of Early-Onset Thrombocytopenia in Preterm Neonates
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Thrombocytopenia is the most common hematologic abnormality diagnosed in the neonatal intensive care unit (NICU). We investigated the causes and neonatal outcomes of early-onset thrombocytopenia in preterm neonates and compared clinical outcomes between neonates in an early-onset thrombocytopenia group who have received and those who have not received platelet transfusion in order to assess the clinical significance of early-onset thrombocytopenia in preterm infants. Methods: We retrospectively reviewed the medical records of preterm neonates born earlier than 34 weeks’ gestation who were admitted to the NICU between January 2005 and September 2014. 412 preterm neonates born earlier than 34 weeks’ gestation were enrolled. The early-onset thrombocytopenia group (n=90) had a platelet count ≤150,000/mL within the first 72 hours of life. We investigated maternal and neonatal characteristics, and neonatal outcomes in the group and compared these with those of a control group (n=322). Results: The neonates with early-onset thrombocytopenia tended to have lower gestational age, birth weight and Apgar scores than controls. Maternal hypertension and lower Apgar score at birth were predictive factors of early-onset thrombocytopenia. No differences in clinical outcomes were observed between the two groups. Clinical outcomes did not significantly different between the groups regardless of whether the neonates received platelet transfusion or not. Conclusion: Early-onset thrombocytopenia had no effect on the neonatal outcomes of the preterm infants. Platelet transfusion did not affect the clinical outcomes of the neonates in the early-onset thrombocytopenia group. Thus, we suggest a lager controlled study on early-onset thrombocytopenia in newborns in order to establish more-efficient treatment guidelines.
Abstract
Purpose: Thrombocytopenia is the most common hematologic abnormality diagnosed in the neonatal intensive care unit (NICU). We investigated the causes and neonatal outcomes of early-onset thrombocytopenia in preterm neonates and compared clinical outcomes between neonates in an early-onset thrombocytopenia group who have received and those who have not received platelet transfusion in order to assess the clinical significance of early-onset thrombocytopenia in preterm infants. Methods: We retrospectively reviewed the medical records of preterm neonates born earlier than 34 weeks’ gestation who were admitted to the NICU between January 2005 and September 2014. 412 preterm neonates born earlier than 34 weeks’ gestation were enrolled. The early-onset thrombocytopenia group (n=90) had a platelet count ≤150,000/mL within the first 72 hours of life. We investigated maternal and neonatal characteristics, and neonatal outcomes in the group and compared these with those of a control group (n=322). Results: The neonates with early-onset thrombocytopenia tended to have lower gestational age, birth weight and Apgar scores than controls. Maternal hypertension and lower Apgar score at birth were predictive factors of early-onset thrombocytopenia. No differences in clinical outcomes were observed between the two groups. Clinical outcomes did not significantly different between the groups regardless of whether the neonates received platelet transfusion or not. Conclusion: Early-onset thrombocytopenia had no effect on the neonatal outcomes of the preterm infants. Platelet transfusion did not affect the clinical outcomes of the neonates in the early-onset thrombocytopenia group. Thus, we suggest a lager controlled study on early-onset thrombocytopenia in newborns in order to establish more-efficient treatment guidelines.
참고문헌 (24)
- Roberts I, "Neonatal thrombocytopenia", Semin Fetal Neonatal Med, 13, pp.256~264 (2008)
- Sola-Visner M, "Neontal thrombocytopenia:what we do and don’t know", Early Hum Dev, 84, pp.499~506 (2008)
- Roberts I, "Neonatal thrombocytopenia: causes and management", Arch Dis Child Fetal Neonatal Ed, 88, pp.F359~364 (2003)
- Stanworth SJ, "Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates", Hematology Am Soc Hematol Educ Program, 2012, pp.512~516 (2012)
- Sola-Visner M, "Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies", Hematology Am Soc Hematol Educ Program, 2012, pp.506~511 (2012)
- Ferrer-Marin F, "Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice", Transfusion, 53, pp.2814~2821 (2013)
- Charkravoty S, "How I manage neonatal thrombocytopenia", Br J Haematol, 156, pp.155~162 (2012)
- Kahn DJ, "Inter-NICU variation in rates and management of thrombocytopenia among very low birth weight infants", J Perinatol, 23, pp.312~316 (2003)
- Christensen RD, "The CBC:reference ranges for neonates", Semin Perinatol, 33, pp.3~11 (2009)
- Wiedmeier SE, "Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system", J Perinatol, 29, pp.130~136 (2009)
- Baer VL, "Severe thrombocytopenia in the NICU", Pediatrics, 124, pp.e1095~1100 (2009)
- Vecchio A, "Evaluation and management of thrombocytopenic neonates in the intensive care unit", Early Hum Dev, 90, pp.S51~55 (2014)
- 최장환, "초극소저체중출생아의 조기 발생 혈소판 감소증의 위험인자 및 예후에 관한 고찰", 대한주산의학회잡지, 23(4), pp.251~258 (2012), 대한주산의학회
- Stanworth SJ, "How to tackle bleeding and thrombosis in the newborn", Early Hum Dev, 84, pp.507~513 (2008)
- Holzhauer S, "Diagnosis and management of neonatal thrombocytopenia", Semin Fetal Neonatal Med, 16, pp.305~310 (2011)
- 성태정, "Disorders in Hemostasis", Neonatal medicine, 18(1), pp.14~22 (2011), 대한신생아학회
- Evans N, "Diagnosis of preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound?", Semin Perinatol, 36, pp.114~122 (2012)
- Papil LA, "Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birh weights less than 1,500 gm", J pediatr, 92, pp.529~534 (1978)
- Bell MJ, "Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging", Ann Surg, 187, pp.1~7 (1978)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
- Lodha A, "Role of hemocoagulase in pulmonary hemorrhage in preterm infants:a systematic review", Indian J Pediatr, 78, pp.838~844 (2011)
- Beiner ME, "Risk factors for neonatal thrombocytopenia in preterm infants", Am J Perinatol, 20, pp.49~54 (2003)
- Boutaybi N, "Early-onset thrombocytopenia in nearterm and term infants with perinatal asphyxia", Vox Sang, 106, pp.361~367 (2014)
- Gibson BE, "Transfusion guidelines for neonates and older children", Br J Hematol, 124, pp.433~453 (2004)